n-hydroxy-4-phosphonobutanamide has been researched along with fosfomycin in 1 studies
| Studies (n-hydroxy-4-phosphonobutanamide) | Trials (n-hydroxy-4-phosphonobutanamide) | Recent Studies (post-2010) (n-hydroxy-4-phosphonobutanamide) | Studies (fosfomycin) | Trials (fosfomycin) | Recent Studies (post-2010) (fosfomycin) |
|---|---|---|---|---|---|
| 6 | 0 | 3 | 2,335 | 181 | 1,022 |
| Protein | Taxonomy | n-hydroxy-4-phosphonobutanamide (IC50) | fosfomycin (IC50) |
|---|---|---|---|
| UDP-N-acetylglucosamine 1-carboxyvinyltransferase | Escherichia coli K-12 | 3.5795 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, TJ; Grosdemange-Billiard, C; Hemmerlin, A; Kuntz, L; Rohmer, M; Tritsch, D; Willem, A | 1 |
1 other study(ies) available for n-hydroxy-4-phosphonobutanamide and fosfomycin
| Article | Year |
|---|---|
Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
Topics: Aldose-Ketose Isomerases; Anti-Bacterial Agents; Antimalarials; Butyrates; Drug Design; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Hydroxamic Acids; Microbial Sensitivity Tests; Multienzyme Complexes; NADP; Organophosphonates; Oxidoreductases; Terpenes | 2005 |